Göbel, A., Rachner, T. D., Hoffmann, O., Klotz, D. M., Kasimir-Bauer, S., Kimmig, R., . . . Bittner, A. (2024). High serum levels of leucine-rich α-2 glycoprotein 1 (LRG-1) are associated with poor survival in patients with early breast cancer. Archives of gynecology and obstetrics, 309(6), . https://doi.org/10.1007/s00404-024-07434-0
Chicago Style (17th ed.) CitationGöbel, Andy, Tilman Daniel Rachner, Oliver Hoffmann, Daniel Martin Klotz, Sabine Kasimir-Bauer, Rainer Kimmig, Lorenz Hofbauer, and Ann-Kathrin Bittner. "High Serum Levels of Leucine-rich α-2 Glycoprotein 1 (LRG-1) Are Associated with Poor Survival in Patients with Early Breast Cancer." Archives of Gynecology and Obstetrics 309, no. 6 (2024). https://doi.org/10.1007/s00404-024-07434-0.
MLA (9th ed.) CitationGöbel, Andy, et al. "High Serum Levels of Leucine-rich α-2 Glycoprotein 1 (LRG-1) Are Associated with Poor Survival in Patients with Early Breast Cancer." Archives of Gynecology and Obstetrics, vol. 309, no. 6, 2024, https://doi.org/10.1007/s00404-024-07434-0.